ZA936968B - Transcutaneous in vivo activation of photosensitive agents in blood - Google Patents

Transcutaneous in vivo activation of photosensitive agents in blood

Info

Publication number
ZA936968B
ZA936968B ZA936968A ZA936968A ZA936968B ZA 936968 B ZA936968 B ZA 936968B ZA 936968 A ZA936968 A ZA 936968A ZA 936968 A ZA936968 A ZA 936968A ZA 936968 B ZA936968 B ZA 936968B
Authority
ZA
South Africa
Prior art keywords
target cells
cells
transcutaneous
blood
vivo activation
Prior art date
Application number
ZA936968A
Other languages
English (en)
Inventor
Anna M Richter
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of ZA936968B publication Critical patent/ZA936968B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA936968A 1992-09-21 1993-09-21 Transcutaneous in vivo activation of photosensitive agents in blood ZA936968B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94811392A 1992-09-21 1992-09-21

Publications (1)

Publication Number Publication Date
ZA936968B true ZA936968B (en) 1994-04-12

Family

ID=25487290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936968A ZA936968B (en) 1992-09-21 1993-09-21 Transcutaneous in vivo activation of photosensitive agents in blood

Country Status (21)

Country Link
US (2) US5484803A (fr)
EP (1) EP0660712B1 (fr)
JP (2) JP3598306B2 (fr)
AT (1) ATE201596T1 (fr)
AU (1) AU681088B2 (fr)
CA (1) CA2144327C (fr)
DE (1) DE69330277T2 (fr)
DK (1) DK0660712T3 (fr)
ES (1) ES2160600T3 (fr)
FI (1) FI951295A (fr)
GR (1) GR3036479T3 (fr)
HU (1) HU220251B (fr)
IL (1) IL107035A (fr)
NO (1) NO951066L (fr)
NZ (1) NZ255302A (fr)
PL (1) PL308116A1 (fr)
PT (1) PT660712E (fr)
SK (1) SK35295A3 (fr)
TW (1) TW241204B (fr)
WO (1) WO1994006424A1 (fr)
ZA (1) ZA936968B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5798238A (en) * 1990-04-16 1998-08-25 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
US5587490A (en) * 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
DE69334009T2 (de) * 1992-11-20 2006-11-23 The University Of British Columbia, Vancouver Verfahren zur Aktivierung von photoempfindlichen Mitteln
WO1996039188A1 (fr) * 1995-06-05 1996-12-12 Queen's University At Kingston Procede photochimiotherapeutique faisant appel a de l'acide 5-aminolevulinique ainsi qu'a d'autres precurseurs de porphyrines endogenes
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
EP0881874B1 (fr) * 1995-11-06 2003-04-02 New York Blood Center, Inc. Traitement pour inactiver des virus effectue sur des globules rouges, en utilisant des phtalocyanines et l'infra rouge
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
US6159733A (en) * 1996-06-20 2000-12-12 New York Blood Center, Inc. Method for photoinactivating malignant cells
US5922278A (en) † 1996-11-19 1999-07-13 Baxter International Inc. Method and apparatus for inactivating contaminants in biological fluid
US5742380A (en) * 1996-12-31 1998-04-21 Ronn Avigdor M Plasma assay spectrometer
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
US5856566A (en) 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
US6159178A (en) 1998-01-23 2000-12-12 Heartport, Inc. Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested
US6096066A (en) * 1998-09-11 2000-08-01 Light Sciences Limited Partnership Conformal patch for administering light therapy to subcutaneous tumors
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
AU2412800A (en) * 1999-01-15 2000-08-01 Light Sciences Corporation Noninvasive vascular therapy
CA2358662A1 (fr) * 1999-01-15 2000-07-20 James Chen Compositions et procedes destines au traitement de troubles metaboliques osseux et de metastases osseuses
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
DE19960705A1 (de) * 1999-12-16 2001-06-21 Laser & Med Tech Gmbh Verfahren und Vorrichtung zur Herstellung eines autologen Immunisierungsimpfstoffes gegen Krebserkrankungen (Tumorvakzine)
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
JP2003519670A (ja) * 2000-01-12 2003-06-24 ライト サイエンシーズ コーポレイション 眼疾患の新規処置
KR100365151B1 (ko) * 2000-05-08 2003-02-11 김형락 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도
DE10034673C1 (de) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
EP2248536A3 (fr) 2000-12-14 2010-12-08 The General Hospital Corporation doing business as Massachusetts General Hospital Thérapie photodynamique de l'acné vulgaire par application topique d'acide aminolévulinique
DE60141758D1 (en) 2000-08-16 2010-05-20 Gen Hospital Corp Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
WO2002100326A2 (fr) * 2001-05-01 2002-12-19 The General Hospital Corporation Photoimmunotherapies permettant de traiter un cancer a l'aide d'immunoconjugues de photosensibilisant et de therapies de combinaison
DE60219627T2 (de) * 2001-06-04 2008-02-07 The General Hospital Corp., Boston Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen
DE10162712A1 (de) * 2001-12-19 2003-07-17 Blutspendienst Der Landesverba Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten
CA2473924A1 (fr) * 2002-01-23 2003-07-31 Light Sciences Corporation Systemes et procedes pour une therapie photodynamique
AU2003249742A1 (en) 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
US7659301B2 (en) * 2003-04-15 2010-02-09 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
WO2004099375A2 (fr) * 2003-04-30 2004-11-18 The General Hospital Corporation Immunoconjugues a photosensibilisateur lie indirectement, leurs procedes de production et d'utilisation
EP1633337A4 (fr) * 2003-05-29 2007-09-05 Mitos Pharmaceuticals Inc Methodes d'utilisation de nitroxydes conjointement avec des photosensibilisants et des sonosensibilisants
FR2857264A1 (fr) * 2003-07-09 2005-01-14 Maco Pharma Sa Procede d'inactivation photodynamique des pathogenes au moyen d'ala
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
US8585707B2 (en) 2006-06-07 2013-11-19 Gary S. Rogers Continuous low irradiance photodynamic therapy method
US20080164224A1 (en) * 2007-01-04 2008-07-10 Whirlpool Corporation System for connecting mechnically dissimilar consumer electronic devices to an adaptor or a host
CA2724949A1 (fr) 2007-06-27 2008-12-31 The General Hospital Corporation Procede et appareil d'inhibition optique de traitement photodynamique
US20090062724A1 (en) * 2007-08-31 2009-03-05 Rixen Chen System and apparatus for sonodynamic therapy
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
JP2014518547A (ja) 2011-04-07 2014-07-31 フェンウォール、インコーポレイテッド 削減された残存血漿容積を有する血小板濃縮物を提供するための自動化方法とシステムおよびそのような血小板濃縮物のための貯蔵媒体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses

Also Published As

Publication number Publication date
ATE201596T1 (de) 2001-06-15
HUT70966A (en) 1995-11-28
FI951295A (fi) 1995-05-17
JP3598306B2 (ja) 2004-12-08
NO951066D0 (no) 1995-03-20
DK0660712T3 (da) 2001-08-27
PT660712E (pt) 2001-11-30
EP0660712A1 (fr) 1995-07-05
AU681088B2 (en) 1997-08-21
NO951066L (no) 1995-05-19
HU220251B (hu) 2001-11-28
CA2144327C (fr) 2002-08-06
TW241204B (fr) 1995-02-21
EP0660712B1 (fr) 2001-05-30
DE69330277T2 (de) 2002-04-18
AU4940593A (en) 1994-04-12
CA2144327A1 (fr) 1994-03-31
JP2001316288A (ja) 2001-11-13
JPH08501301A (ja) 1996-02-13
IL107035A0 (en) 1993-12-28
PL308116A1 (en) 1995-07-24
WO1994006424A1 (fr) 1994-03-31
US5736563A (en) 1998-04-07
ES2160600T3 (es) 2001-11-16
FI951295A0 (fi) 1995-03-20
GR3036479T3 (en) 2001-11-30
SK35295A3 (en) 1996-05-08
DE69330277D1 (de) 2001-07-05
NZ255302A (en) 2001-04-27
IL107035A (en) 1998-12-27
US5484803A (en) 1996-01-16

Similar Documents

Publication Publication Date Title
GR3036479T3 (en) Transcutaneous in vivo activation of photosensitive agents in blood.
AU1934699A (en) Diode laser irradiation and electrotherapy system for biological tissue stimulation
CA2109084A1 (fr) Methode de destruction de films biologiques
EP0361936A3 (fr) Compositions pour obtenir un effet laser et leurs méthodes d'utilisation
CA2199117A1 (fr) Composes et procedes de traitement du cancer
NZ503340A (en) Treatment for hairy hoof warts (papiliomatous digital dermatitis, or PDD)
EP1114653A3 (fr) Un dispositif de cardioversion implantable à seuil auto-adaptatif pour procédés de sélection thérapeutique
HK1040053A1 (en) Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
FR2780290B1 (fr) Dispositif medical implantable actif asservi tel que stimulateur cardiaque, defibrillateur et/ou cardioverteur, notamment de type multisites
FR2772622B1 (fr) Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou cardioverteur, de type multisite configurable
DE69623390T2 (de) Aktive implantierbare medizinische Vorrichtung, insbesondere Herzschrittmacher oder Defibrillator
PT768886E (pt) Efeitos de revestimento endotelial e tratamento de desordens vasospasticas
FR2774916B1 (fr) Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou cardioverteur, de type multisite
MX9407876A (es) Formulaciones de hongos entomopatogenos para uso como insecticidas biologicos.
ZA858237B (en) Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz
EP0950416A4 (fr) Agent preventif et/ou curatif de la cachexie
UA37251C2 (uk) Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в
AU8168294A (en) Solid insecticidal formulation
EP0539516A4 (fr)
DE69937797D1 (de) Alpha-emittierende konstrukte sowie deren verwendung
RU96118110A (ru) Предупреждение разрушения эритроцитов, стерилизованных фталоцианином и светом в присутствии витамина e и его производных
RU95103472A (ru) Способ лечения заразных форм сифилиса
IT8920322A0 (it) Procedimento di lotta biologica contro l'insetto distruttore di colture plutella xylostella utilizzante una poliedrosi nucleare e almeno un piretrinoide di sintesi.